- Home
- KRKR vs PSTV Comparison
KRKR vs PSTV Comparison
Compare KRKR & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- PSTV
- Stock Information
- Founded
- KRKR 2010
- PSTV 1996
- Country
- KRKR China
- PSTV United States
- Employees
- KRKR N/A
- PSTV N/A
- Industry
- KRKR Business Services
- PSTV Medical/Dental Instruments
- Sector
- KRKR Consumer Discretionary
- PSTV Health Care
- Exchange
- KRKR Nasdaq
- PSTV Nasdaq
- Market Cap
- KRKR 11.7M
- PSTV 10.4M
- IPO Year
- KRKR 2019
- PSTV N/A
- Fundamental
- Price
- KRKR $5.78
- PSTV $0.36
- Analyst Decision
- KRKR
- PSTV Strong Buy
- Analyst Count
- KRKR 0
- PSTV 3
- Target Price
- KRKR N/A
- PSTV $10.83
- AVG Volume (30 Days)
- KRKR 2.7K
- PSTV 67.2M
- Earning Date
- KRKR 03-11-2025
- PSTV 08-13-2025
- Dividend Yield
- KRKR N/A
- PSTV N/A
- EPS Growth
- KRKR N/A
- PSTV N/A
- EPS
- KRKR N/A
- PSTV N/A
- Revenue
- KRKR $31,657,328.00
- PSTV $5,206,000.00
- Revenue This Year
- KRKR $182.55
- PSTV $13.26
- Revenue Next Year
- KRKR N/A
- PSTV $8.84
- P/E Ratio
- KRKR N/A
- PSTV N/A
- Revenue Growth
- KRKR N/A
- PSTV N/A
- 52 Week Low
- KRKR $2.76
- PSTV $0.16
- 52 Week High
- KRKR $12.99
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- KRKR 53.05
- PSTV 47.17
- Support Level
- KRKR $5.55
- PSTV $0.17
- Resistance Level
- KRKR $5.88
- PSTV $0.44
- Average True Range (ATR)
- KRKR 0.09
- PSTV 0.05
- MACD
- KRKR -0.04
- PSTV 0.02
- Stochastic Oscillator
- KRKR 38.98
- PSTV 55.39
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).